New topical treatments for hereditary hair loss
Treatments studied
Part of Skin clinical trials.
This study tests two new topical treatments for hereditary hair loss. It may help you regrow hair or slow further thinning.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older.
- A doctor has confirmed you have hereditary hair loss (also called androgenetic alopecia).
- You are willing to apply the treatment exactly as told and attend all study visits.
- You are generally healthy overall.
- You are not pregnant, breastfeeding, or planning to become pregnant during the study.
- You have not used prescription scalp treatments or had scalp procedures within the last month.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new scalp product called DA-001 to see if it reduces hair shedding and helps hair grow back in people with telogen effluvium. It's a clinical trial that compares the treatment to a placebo (a product without the active ingredient) to find out if it works.
This study tests if a topical solution with dutasteride can help regrow hair in men with androgenetic alopecia (male pattern baldness). It might slow hair loss and promote new growth, giving a non-invasive option.
This trial compares different in-office procedures (like injections, lasers, or platelet-rich plasma) to treat male pattern hair loss. It aims to find which method works best to help hair grow back or stop thinning. Participation could provide access to new treatments that target the root cause of hair loss.
This study tests a new treatment for female pattern hair loss in women aged 18 to 50. It aims to see if the treatment is safe and effective for regrowing hair.
This study tests an experimental medication (CKD-843) for men with male pattern baldness. It aims to see if the treatment is safe and effective for regrowing hair.
This study tests an investigational topical medication called PP405 for male pattern hair loss. It aims to see if the treatment is safe and effective for regrowing hair in men with moderate balding.
Hear when a new Androgenetic Alopecia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.